Literature DB >> 22683325

Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy.

Jennifer Davis1, Soichiro Yasuda, Nathan J Palpant, Joshua Martindale, Tamara Stevenson, Kimber Converso, Joseph M Metzger.   

Abstract

Restrictive cardiomyopathy (RCM) has been linked to mutations in the thin filament regulatory protein cardiac troponin I (cTnI). As the pathogenesis of RCM from genotype to clinical phenotype is not fully understood, transgenic (Tg) mice were generated with cardiac specific expression of an RCM-linked missense mutation (R193H) in cTnI. R193H Tg mouse hearts with 15% stoichiometric replacement had smaller hearts and significantly elevated end diastolic pressures (EDP) in vivo. Using a unique carbon microfiber-based assay, membrane intact R193H adult cardiac myocytes generated higher passive tensions across a range of physiologic sarcomere lengths resulting in significant Ca(2+) independent cellular diastolic tone that was manifest in vivo as elevated organ-level EDP. Sarcomere relaxation and Ca(2+) decay was uncoupled in isolated R193H Tg adult myocytes due to the increase in myofilament Ca(2+) sensitivity of tension, decreased passive compliance of the sarcomere, and adaptive in vivo changes in which phospholamban (PLN) content was decreased. Further evidence of Ca(2+) and mechanical uncoupling in R193H Tg myocytes was demonstrated by the biphasic response of relaxation to increased pacing frequency versus the negative staircase seen with Ca(2+) decay. In comparison, non-transgenic myocyte relaxation closely paralleled the accelerated Ca(2+) decay. Ca(2+) transient amplitude was also significantly blunted in R193H Tg myocytes despite normal mechanical shortening resulting in myocyte hypercontractility when compared to non-transgenics. These results identify for the first time that a single point mutation in cTnI, R193H, directly causes elevated EDP due to a myocyte intrinsic loss of compliance independent of Ca(2+) cycling or altered cardiac morphology. The compound influence of impaired relaxation and elevated EDP represents a clinically severe form of diastolic dysfunction similar to the hemodynamic state documented in RCM patients.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22683325      PMCID: PMC3443869          DOI: 10.1016/j.yjmcc.2012.05.018

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  46 in total

1.  A novel method to study contraction characteristics of a single cardiac myocyte using carbon fibers.

Authors:  S I Yasuda; S Sugiura; N Kobayakawa; H Fujita; H Yamashita; K Katoh; Y Saeki; H Kaneko; Y Suda; R Nagai; H Sugi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-09       Impact factor: 4.733

2.  Contemporary evaluation and management of hypertrophic cardiomyopathy.

Authors:  Eugene Braunwald; Christine E Seidman; Ulrich Sigwart
Journal:  Circulation       Date:  2002-09-10       Impact factor: 29.690

3.  Chimera analysis of troponin I domains that influence Ca(2+)-activated myofilament tension in adult cardiac myocytes.

Authors:  M V Westfall; F P Albayya; I I Turner; J M Metzger
Journal:  Circ Res       Date:  2000-03-03       Impact factor: 17.367

4.  An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.

Authors:  D Fatkin; B K McConnell; J O Mudd; C Semsarian; I G Moskowitz; F J Schoen; M Giewat; C E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

5.  Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.

Authors:  B C Knollmann; J D Potter
Journal:  Trends Cardiovasc Med       Date:  2001-07       Impact factor: 6.677

6.  Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy.

Authors:  J James; Y Zhang; H Osinska; A Sanbe; R Klevitsky; T E Hewett; J Robbins
Journal:  Circ Res       Date:  2000-10-27       Impact factor: 17.367

7.  Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy.

Authors:  Yuejin Li; Pierre-Yves Jean Charles; Changlong Nan; Jose Renato Pinto; Yingcai Wang; Jingsheng Liang; Gang Wu; Jie Tian; Han-Zhong Feng; James D Potter; J-P Jin; Xupei Huang
Journal:  J Mol Cell Cardiol       Date:  2010-05-15       Impact factor: 5.000

8.  The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.

Authors:  Christopher Semsarian; Imran Ahmad; Michael Giewat; Dimitrios Georgakopoulos; Joachim P Schmitt; Bradley K McConnell; Steven Reiken; Ulrike Mende; Andrew R Marks; David A Kass; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

9.  A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.

Authors:  C Semsarian; M J Healey; D Fatkin; M Giewat; C Duffy; C E Seidman; J G Seidman
Journal:  J Mol Cell Cardiol       Date:  2001-11       Impact factor: 5.000

10.  Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.

Authors:  Daniel E Michele; Carlen A Gomez; Katie E Hong; Margaret V Westfall; Joseph M Metzger
Journal:  Circ Res       Date:  2002-08-09       Impact factor: 17.367

View more
  16 in total

1.  Advancing physiological maturation in human induced pluripotent stem cell-derived cardiac muscle by gene editing an inducible adult troponin isoform switch.

Authors:  Matthew Wheelwright; Jennifer Mikkila; Fikru B Bedada; Mohammad A Mandegar; Brian R Thompson; Joseph M Metzger
Journal:  Stem Cells       Date:  2020-06-16       Impact factor: 6.277

Review 2.  Cell biology of sarcomeric protein engineering: disease modeling and therapeutic potential.

Authors:  Brian R Thompson; Joseph M Metzger
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

3.  Cardiac troponin I Pro82Ser variant induces diastolic dysfunction, blunts β-adrenergic response, and impairs myofilament cooperativity.

Authors:  Genaro A Ramirez-Correa; Aisha H Frazier; Guangshuo Zhu; Pingbo Zhang; Thomas Rappold; Viola Kooij; Djahida Bedja; Greg A Snyder; Nahyr S Lugo-Fagundo; Raena Hariharan; Yuejin Li; Xiaoxu Shen; Wei Dong Gao; Oscar H Cingolani; Eiki Takimoto; D Brian Foster; Anne M Murphy
Journal:  J Appl Physiol (1985)       Date:  2014-10-16

4.  Sarcomere neutralization in inherited cardiomyopathy: small-molecule proof-of-concept to correct hyper-Ca2+-sensitive myofilaments.

Authors:  Brian R Thompson; Joshua Martindale; Joseph M Metzger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-13       Impact factor: 4.733

5.  In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene.

Authors:  Adriano S Martins; Michelle S Parvatiyar; Han-Zhong Feng; J Martijn Bos; David Gonzalez-Martinez; Milica Vukmirovic; Rajdeep S Turna; Marcos A Sanchez-Gonzalez; Crystal-Dawn Badger; Diego A R Zorio; Rakesh K Singh; Yingcai Wang; J-P Jin; Michael J Ackerman; Jose R Pinto
Journal:  Circ Cardiovasc Genet       Date:  2015-08-24

6.  Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performance.

Authors:  Wang Wang; Matthew S Barnabei; Michelle L Asp; Frazer I Heinis; Erik Arden; Jennifer Davis; Elizabeth Braunlin; Qi Li; Jonathan P Davis; James D Potter; Joseph M Metzger
Journal:  Nat Med       Date:  2013-02-10       Impact factor: 53.440

7.  Analysis of the molecular pathogenesis of cardiomyopathy-causing cTnT mutants I79N, ΔE96, and ΔK210.

Authors:  Fan Bai; Hannah M Caster; Jose R Pinto; Masataka Kawai
Journal:  Biophys J       Date:  2013-05-07       Impact factor: 4.033

8.  A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy.

Authors:  Jennifer Davis; L Craig Davis; Robert N Correll; Catherine A Makarewich; Jennifer A Schwanekamp; Farid Moussavi-Harami; Dan Wang; Allen J York; Haodi Wu; Steven R Houser; Christine E Seidman; Jonathan G Seidman; Michael Regnier; Joseph M Metzger; Joseph C Wu; Jeffery D Molkentin
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

9.  Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.

Authors:  David Dweck; Marcos A Sanchez-Gonzalez; Audrey N Chang; Raul A Dulce; Crystal-Dawn Badger; Andrew P Koutnik; Edda L Ruiz; Brittany Griffin; Jingsheng Liang; Mohamed Kabbaj; Frank D Fincham; Joshua M Hare; J Michael Overton; Jose R Pinto
Journal:  J Biol Chem       Date:  2014-06-27       Impact factor: 5.157

10.  Sarcomere integrated biosensor detects myofilament-activating ligands in real time during twitch contractions in live cardiac muscle.

Authors:  Anthony D Vetter; Ashley A Martin; Brian R Thompson; David D Thomas; Joseph M Metzger
Journal:  J Mol Cell Cardiol       Date:  2020-08-11       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.